BiomEdit logo

BiomEdit jobs and careers

About BiomEdit

BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most important problems in animal agriculture and food security by leveraging the potential of themicrobiome. BiomEdit’s technology is based on a unique platform that utilizes high-throughput sequencing and data analytics to rapidly discover and screen novel probiotic species and bioactive molecules. These can then be engineered to confer thermostability, enhanced production of beneficial metabolites, or expression of immune modulating proteins. These probiotics and microbially-derived compounds represent the next generation of products designed to promote animal health without the use of antibiotics.

Founded in 2022 by Aaron Schacht.

Founded
2022
Employees
11 to 50
Total funding
$48.5M

Leadership

The top of BiomEdit's org chart, with how many people report into each leader.

ASPhoto of Aaron Schacht

Aaron Schacht

Chief Executive Officer and Board Director

13 reports

AMPhoto of Arvind Kumar (Mahajan)

Arvind Kumar (Mahajan)

VP Research

4 reports

KBPhoto of Kristin Bloink

Kristin Bloink

Vice President, Product Development, Biomedit

3 reports

EH

Emily Bulian Helmes

Vice President, Regulatory

1 report

DSPhoto of Dr. J. Bruce Schelkopf

Dr. J. Bruce Schelkopf

General Counsel, Company Secretary and Chief IP Officer

EYPhoto of Eric Young

Eric Young

Chief Financial Officer and Chief Business Officer